Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.
Zacks Investment Research8/3/2026Negative
AVTR
Avantor IncNYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$9.13B
P/E Ratio
—
EPS
$-0.84
Beta
0.89
52W High
$15.93
52W Low
$7.26
50-Day MA
$11.18
200-Day MA
$10.17
Dividend Yield
—
Profit Margin
-8.81%
Forward P/E
16.75
PEG Ratio
—
About Avantor Inc
Avantor, Inc. provides products and services to clients in the biopharmaceutical, healthcare, education and government, advanced technologies and applied materials industries in America, Europe, Asia, the Middle East and Africa. The company is headquartered in Radnor, Pennsylvania.
Fundamentals
| Revenue (TTM) | $6.56B |
| Gross Profit (TTM) | $2.09B |
| EBITDA | $943.70M |
| Operating Margin | 7.16% |
| Return on Equity | -9.70% |
| Return on Assets | 2.69% |
| Revenue/Share (TTM) | $9.68 |
| Book Value | $8.32 |
| Price-to-Book | 1.64 |
| Price-to-Sales (TTM) | 1.39 |
| EV/Revenue | 1.925 |
| EV/EBITDA | 111.87 |
| Quarterly Earnings Growth (YoY) | -37.40% |
| Quarterly Revenue Growth (YoY) | 0.50% |
| Shares Outstanding | $676.36M |
| Float | $657.84M |
| % Insiders | 1.50% |
| % Institutions | 105.38% |
Historical Volatility
HV 10-Day
25.25%
HV 20-Day
61.44%
HV 30-Day
61.34%
HV 60-Day
53.31%
HV Rank
77.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.56 target)
3
Buy11
Hold2
Sell1
Strong SellLatest News
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Zacks Investment Research7/31/2026Positive
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.
Zacks Investment Research7/30/2026Positive
Avantor Q2 Earnings Call Highlights
Avantor NYSE: AVTR reported second-quarter 2026 results that exceeded its expectations on several measures, supported by a return to organic growth in its VWR Distribution & Services segment, strong free cash flow and progress under its Revival operational improvement program.
MarketBeat7/29/2026Positive
Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Seeking Alpha7/29/2026Neutral
Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research7/29/2026Positive
Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago.
Zacks Investment Research7/29/2026Positive
Avantor® Reports Second Quarter 2026 Results
Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4% Net income of $38.1 million; Adjusted EBITDA of $254.3 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.21 Operating cash flow of $178.2 million; free cash flow of $142.8 million Increases FY 2026 organic revenue growth and adjusted EPS guidance RADNOR, Pa., July 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports better than expected results for the second fiscal quarter of 2026.
PRNewsWire7/29/2026Neutral
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Avantor (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Investment Research7/22/2026Positive
AVTR vs. ICLR: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors?
Zacks Investment Research7/21/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AVTR and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 8/18/2026